Bantam Pharmaceutical Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 7

Employees
  • Latest Deal Type
  • Series A

  • (Cancelled)
  • Investors
  • 3

Bantam Pharmaceutical General Information

Description

Operator of drug discovery company intended for developing therapeutics that address the unmet needs of cancer patients. The company offers a new therapeutic approach featuring the tumor-killing potency of chemotherapy but with the selectivity of targeted therapy that will expand the treatment options for relapsed and refractory lymphomas and difficult-to-treat solid tumors, enabling patients to effectively fight cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 8 Davis Drive
  • Durham
  • England, United Kingdom
+44 0000000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bantam Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 16-Sep-2021 Cancelled Clinical Trials - General
2. Seed Round 16-Sep-2021 0000 0000 Completed Clinical Trials - General
1. Seed Round 11-Aug-2015 $7M $7M Completed Startup
To view Bantam Pharmaceutical’s complete valuation and funding history, request access »

Bantam Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of drug discovery company intended for developing therapeutics that address the unmet needs of cancer patients.
Drug Discovery
Durham, United Kingdom
7 As of 2022
0000
00000000000

000000

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bantam Pharmaceutical Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00000 Corporation Mumbai, India 00000 00000000
00000000 Formerly VC-backed San Diego, CA 00000 00000 0000000000 00000
To view Bantam Pharmaceutical’s complete competitors history, request access »

Bantam Pharmaceutical Patents

Bantam Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020283129-A1 Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative Pending 31-May-2019 0000000000
CA-3142196-A1 Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative Pending 31-May-2019 0000000000
CA-3142356-A1 Methods for making thiazolylpyrazole carboxylic acids and intermediates therefor Pending 31-May-2019 0000000000
EP-3976605-A1 Methods for making thiszolylpyrazole carboxylic acids and intermediates therefor Pending 31-May-2019 0000000000
JP-2022535228-A Process for the preparation of thiazolylpyrazole carboxylic acids and intermediates therefor Pending 31-May-2019 C07D417/04
To view Bantam Pharmaceutical’s complete patent history, request access »

Bantam Pharmaceutical Executive Team (4)

Name Title Board Seat Contact Info
Michael Luther Ph.D Founding Co-Chief Executive Officer & Board Advisor
Michael Stocum President, Board Member & Co-Chief Executive Officer
Matthew Kostura Ph.D Chief Scientific Officer
Victor Keen Co-Founder & Board Member
To view Bantam Pharmaceutical’s complete executive team members history, request access »

Bantam Pharmaceutical Board Members (5)

Name Representing Role Since
James Tozer Jr. Bantam Pharmaceutical Board Member 000 0000
Lionel Goldfrank III Bantam Pharmaceutical Board Member 000 0000
Michael Luther Ph.D Bantam Pharmaceutical Founding Co-Chief Executive Officer & Board Advisor 000 0000
Michael Stocum Bantam Pharmaceutical President, Board Member & Co-Chief Executive Officer 000 0000
Victor Keen Bantam Pharmaceutical Co-Founder & Board Member 000 0000
To view Bantam Pharmaceutical’s complete board members history, request access »

Bantam Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bantam Pharmaceutical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Lionel Goldfrank Angel (individual) Minority 000 0000 000000 0
Victor Keen Angel (individual) Minority 000 0000 000000 0
W. James Tozer Angel (individual) Minority 000 0000 000000 0
To view Bantam Pharmaceutical’s complete investors history, request access »